Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to Trauma
Status:
Withdrawn
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). The purpose of this study is
to evaluate the treatment of Recombinant Faction VIIa in Patients with Severe Bleeding Due to
Trauma
Please note that this trial and trial F7TRAUMA-1711 (NCT00184548) have been merged.